MoneyWorks4Me

Shilpa Medicare - Quaterly Results

29 Oct 2021 Evaluate
The Revenue for the quarter ended  September 2021 of Rs. 2858.71 millions grew by 8.83 % from Rs. 2626.78 millions.The Net proft of the company remain more or less same to Rs. 436.22  millions from Rs. 547.78 millions ,decline by -20.37%.The Operating Profit of the company witnessed a decrease to 730.41 millions from 889.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 2858.71 2626.78 8.83 5261.98 4793.14 9.78 8303.16 8059.71 3.02
Other Income 91.06 75.21 21.07 188.97 101.56 86.07 339.00 112.63 200.99
PBIDT 730.41 889.03 -17.84 1231.75 1691.23 -27.17 2609.07 2561.68 1.85
Interest 78.48 33.40 134.97 148.37 68.80 115.65 174.68 43.29 303.51
PBDT 741.02 855.63 -13.39 1172.47 2151.92 -45.52 2963.87 2472.97 19.85
Depreciation 131.25 98.39 33.40 248.11 197.49 25.63 408.48 349.57 16.85
PBT 609.77 757.24 -19.47 924.36 1954.43 -52.70 2555.39 2123.40 20.34
TAX 173.55 209.46 -17.14 236.67 545.23 -56.59 711.47 441.46 61.16
Deferred Tax 67.01 78.66 -14.81 75.17 205.13 -63.35 264.48 50.52 423.52
PAT 436.22 547.78 -20.37 687.69 1409.20 -51.20 1843.92 1681.94 9.63
Equity 81.53 81.53 0.00 81.53 81.53 0.00 81.53 81.53 0.00
PBIDTM(%) 25.55 33.84 -24.51 23.41 35.28 -33.66 31.42 31.78 -1.14
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..